Pharmacogenetic variability of tuberculosis biomarkers in native and mestizo Peruvian populations
Abstract In Peru, 29 292 people were diagnosed with tuberculosis in 2022. Although tuberculosis treatments are effective, 3.4%–13% are associated with significant adverse drug reactions, with drug‐induced liver injury (DILI) considered the most predominant. Among the first‐line antituberculosis drug...
| Main Authors: | , , , , , , , |
|---|---|
| פורמט: | Article |
| שפה: | English |
| יצא לאור: |
Wiley
2024-06-01
|
| סדרה: | Pharmacology Research & Perspectives |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1002/prp2.1179 |